Guoxin Mao

852 total citations
35 papers, 655 citations indexed

About

Guoxin Mao is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Guoxin Mao has authored 35 papers receiving a total of 655 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 15 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Guoxin Mao's work include RNA modifications and cancer (10 papers), Cancer-related molecular mechanisms research (6 papers) and Ubiquitin and proteasome pathways (5 papers). Guoxin Mao is often cited by papers focused on RNA modifications and cancer (10 papers), Cancer-related molecular mechanisms research (6 papers) and Ubiquitin and proteasome pathways (5 papers). Guoxin Mao collaborates with scholars based in China. Guoxin Mao's co-authors include Huijun Zhu, Qun Xue, Shu Zhang, Buyou Chen, Liting Lv, Yixin Zhang, Wei Wang, Tingting Ni, Yifei Liu and Runzhou Ni and has published in prestigious journals such as Journal of Cellular Biochemistry, Talanta and Oncotarget.

In The Last Decade

Guoxin Mao

33 papers receiving 654 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guoxin Mao China 17 511 221 189 83 81 35 655
Huizhi Sun China 16 478 0.9× 313 1.4× 188 1.0× 72 0.9× 76 0.9× 23 641
Dorine Bellanger France 11 330 0.6× 199 0.9× 201 1.1× 79 1.0× 103 1.3× 15 586
Katarzyna B. Leszczyńska United Kingdom 15 476 0.9× 205 0.9× 212 1.1× 85 1.0× 49 0.6× 24 664
Jiadong Chi China 12 425 0.8× 267 1.2× 193 1.0× 73 0.9× 45 0.6× 27 567
Veronica Veschi Italy 16 444 0.9× 181 0.8× 266 1.4× 49 0.6× 114 1.4× 26 701
Yuanke Liang China 16 488 1.0× 238 1.1× 249 1.3× 127 1.5× 62 0.8× 30 752
Viviana Vallacchi Italy 12 465 0.9× 169 0.8× 277 1.5× 64 0.8× 158 2.0× 25 679
Raquel Batlle Spain 7 345 0.7× 190 0.9× 227 1.2× 56 0.7× 87 1.1× 7 552
Hong Qi China 17 430 0.8× 198 0.9× 125 0.7× 61 0.7× 61 0.8× 29 597
Ming Zhuang China 15 559 1.1× 389 1.8× 112 0.6× 87 1.0× 66 0.8× 31 760

Countries citing papers authored by Guoxin Mao

Since Specialization
Citations

This map shows the geographic impact of Guoxin Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guoxin Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guoxin Mao more than expected).

Fields of papers citing papers by Guoxin Mao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guoxin Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guoxin Mao. The network helps show where Guoxin Mao may publish in the future.

Co-authorship network of co-authors of Guoxin Mao

This figure shows the co-authorship network connecting the top 25 collaborators of Guoxin Mao. A scholar is included among the top collaborators of Guoxin Mao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guoxin Mao. Guoxin Mao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Zhiyi, et al.. (2025). Talin1 Ser425 phosphorylation promotes colorectal cancer progression and metastasis. Translational Cancer Research. 14(2). 796–807.
2.
Zhao, Wenjing, et al.. (2022). Perioperative lymphocyte-to-monocyte ratio changes plus CA199 in predicting the prognosis of patients with gastric cancer. Journal of Gastrointestinal Oncology. 13(3). 1007–1021. 3 indexed citations
3.
Gao, Jinfeng, Daorong Hou, Ping Hu, & Guoxin Mao. (2021). Curcumol increases the sensitivity of colon cancer to 5-FU by regulating Wnt/β-catenin signaling. Translational Cancer Research. 10(5). 2437–2450. 19 indexed citations
5.
Liang, Haibin, et al.. (2018). Knockdown of KIF26B inhibits breast cancer cell proliferation, migration, and invasion. OncoTargets and Therapy. Volume 11. 3195–3203. 23 indexed citations
6.
Wang, Yingying, Xiaoling Gu, Chao Wang, et al.. (2016). The far-upstream element-binding protein 2 is correlated with proliferation and doxorubicin resistance in human breast cancer cell lines. Tumor Biology. 37(7). 9755–9769. 16 indexed citations
7.
Gu, Jun, Jie Chen, Jian Feng, et al.. (2016). Overexpression of ADAMTS5 can regulate the migration and invasion of non-small cell lung cancer. Tumor Biology. 37(7). 8681–8689. 20 indexed citations
8.
Chen, Jie, Jun Gu, Jian Feng, et al.. (2015). TAB3 overexpression promotes cell proliferation in non-small cell lung cancer and mediates chemoresistance to CDDP in A549 cells via the NF-κB pathway. Tumor Biology. 37(3). 3851–3861. 13 indexed citations
9.
Liu, Rong, Yingze Wei, Shuyun Yang, et al.. (2015). Spy1 participates in the proliferation and apoptosis of epithelial ovarian cancer. Journal of Molecular Histology. 47(1). 47–57. 9 indexed citations
10.
Ni, Tingting, Guoxin Mao, Qun Xue, et al.. (2015). Upregulated expression of ILF2 in non-small cell lung cancer is associated with tumor cell proliferation and poor prognosis. Journal of Molecular Histology. 46(4-5). 325–335. 34 indexed citations
11.
Liu, Rong, Yan Deng, Shuyun Yang, et al.. (2015). PSMB4 expression associates with epithelial ovarian cancer growth and poor prognosis. Archives of Gynecology and Obstetrics. 293(6). 1297–1307. 22 indexed citations
12.
Liu, Yifei, Tingting Ni, Qun Xue, et al.. (2014). Involvement of p29/SYF2/fSAP29/NTC31 in the progression of NSCLC via modulating cell proliferation. Pathology - Research and Practice. 211(1). 36–42. 10 indexed citations
13.
Ji, Lili, Tingting Ni, Qun Xue, et al.. (2014). Transformer 2β (Tra2β/SFRS10) positively regulates the progression of NSCLC via promoting cell proliferation. Journal of Molecular Histology. 45(5). 573–582. 19 indexed citations
15.
Lv, Liting, Qun Xue, Chunhua Wan, et al.. (2013). Vacuolar protein sorting 4B, an ATPase protein positively regulates the progression of NSCLC via promoting cell division. Molecular and Cellular Biochemistry. 381(1-2). 163–171. 26 indexed citations
16.
Xue, Qun, Liting Lv, Chunhua Wan, et al.. (2013). Expression and clinical role of small glutamine-rich tetratricopeptide repeat (TPR)-containing protein alpha (SGTA) as a novel cell cycle protein in NSCLC. Journal of Cancer Research and Clinical Oncology. 139(9). 1539–1549. 16 indexed citations
17.
Xue, Qun, Yiqun Zhou, Chunhua Wan, et al.. (2013). Epithelial membrane protein 3 is frequently shown as promoter methylation and functions as a tumor suppressor gene in non-small cell lung cancer. Experimental and Molecular Pathology. 95(3). 313–318. 30 indexed citations
18.
Lv, Liting, Chunhua Wan, Buyou Chen, et al.. (2013). Nemo‐Like Kinase (NLK) Inhibits the Progression of NSCLC via Negatively Modulating WNT Signaling Pathway. Journal of Cellular Biochemistry. 115(1). 81–92. 36 indexed citations
19.
Mao, Guoxin. (2012). Expression and significance of OCT_4,CD_(133) in non-small cell lung cancer. 1 indexed citations
20.
Mao, Guoxin. (2012). The relationship between β-tubulin III expression in tumor cells and chemotherapy sensitivity of patients with NSCLC receiving paclitaxel. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026